Trial intelligence / Profile preview

Neuromodulation with lidocaine for chronic post-treatment pain in head and neck, breast, and intrathoracic cancer patients

2008-002085-63Phase 2Active

Sponsor
AOU Città della Salute e della Scienza di Torino
Start
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of lidocaine in chronic pain, scar and cutaneous fibrosis, sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoint: VAS pain improvement. Started May 2008; status: active.

02

Drugs

lidocaine
03

Conditions

chronic painscarcutaneous fibrosis

Beyond the preview

Go deeper on 2008-002085-63.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002085-63.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call